MASLD Pharmacotherapy: Current Standards, Emerging Treatments, and Practical Guidance for Indian Physicians
Journal of The Association of Physicians of India · 2025-07 · 73 (7) · e45-e60
DOI: 10.59556/japi.73.1058 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of The Association of Physicians of India, 2025-07. Verfasst von Ashish Kumar. Beteiligte Einrichtung: Professor, Department of Gastroenterology, Institute of Liver, Gastroenterology, and Pancreatico-Biliary Sciences, Sir Ganga Ram Hospital, Delhi, Ind…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 99 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Professor, Department of Gastroenterology, Institute of Liver, Gastroenterology, and Pancreatico-Biliary Sciences, Sir Ganga Ram Hospital, Delhi, India, Corresponding Author, Orcid: https://orcid.org/0000-0001-6680-7227.
Zitieren
APA
Kumar, A. (2025). MASLD Pharmacotherapy: Current Standards, Emerging Treatments, and Practical Guidance for Indian Physicians. Journal of The Association of Physicians of India, 73(7), e45-e60. https://doi.org/10.59556/japi.73.1058
Vancouver
Kumar A. MASLD Pharmacotherapy: Current Standards, Emerging Treatments, and Practical Guidance for Indian Physicians. Journal of The Association of Physicians of India. 2025;73(7):e45-e60. doi:10.59556/japi.73.1058
BibTeX
@article{Kumar2025,
author = {Kumar, Ashish},
title = {MASLD Pharmacotherapy: Current Standards, Emerging Treatments, and Practical Guidance for Indian Physicians},
journal = {Journal of The Association of Physicians of India},
year = {2025},
volume = {73},
number = {7},
pages = {e45--e60},
doi = {10.59556/japi.73.1058}
}
EUVIMED